Is Swiss Parenterals Ltd a good quality company?

Data is not available for this company.

What is Swiss Parenterals Ltd share price return in the past 10 years?

Data is not available for this company

What is the share price of Swiss Parenterals Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Swiss Parenterals Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Swiss Parenterals?

The latest standalone P/E ratio of Swiss Parenterals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Swiss Parenterals Ltd?

The latest standalone P/B ratio of Swiss Parenterals Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Swiss Parenterals Ltd?

The 52-week high of Swiss Parenterals Ltd is Rs. 0.00 and the 52-week low is Rs. 0.00.

Swiss Parenterals Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Swiss Parenterals Ltd
Brand: Swiss Parenterals

Swiss Parenterals Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Swiss Parenterals Ltd

BSE: 0 NSE:

Key Metrics

Market Cap

₹0 Cr.

P/E Ratio

0.00

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Return on Capital Employed (ROCE)

48.99%

Current Price

₹0

Return on Equity (ROE)

37.69%

Return on Assets (ROA)

23.32%

Operating Profit Margin

30.8%

Net Profit Margin

23.55%

Gross Profit Margin

33.5%

Book Value per Share

₹45.6

Sales Growth (YoY)

24.13%

Sales Growth (3 Years)

85.45%

Operating Profit Growth (1 Year)

40.86%

Operating Profit Growth (3 Years)

100.23%

Net Profit Growth (1 Year)

21.73%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

-49.12%

Dividend Yield

0.00%

Promoter Holding

99.99%

Pledged shares (%)
of Promoter's holding (%)

0.00%

DeciZen - make an informed investing decision on Swiss Parenterals

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	21.4%	18.6%	9.3%	16.1%	27.4%	57.8%	42.4%	49%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	40.7	47	48.4	48.3	56.7	223	291	362	57
Sales YoY Gr.	-	15.7%	2.8%	-0.1%	17.4%	293.9%	30.4%	24.1%	-
Adj EPS ⓘ	8	6.1	1.2	3.3	8.7	75.4	104	151.3	8.8
YoY Gr.	-	-23.9%	-80.7%	180.3%	164.3%	769.1%	38%	45.5%	-
BVPS (₹) ⓘ	26.3	31.9	33.1	0	44.9	369.1	328.6	481	45.6
Adj Net Profit ⓘ	3.8	3.4	0.7	2.4	6.4	55.6	58	84.5	6
Cash Flow from Ops. ⓘ	2.8	7.7	3.9	6.1	3.6	14.5	107	91	-
Debt/CF from Ops. ⓘ	6.5	1.9	4.5	0	4.2	0.7	0.2	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	49.5%	85.5%	24.1%
Adj EPS ⓘ	NA	164.5%	159.4%	45.5%
BVPSⓘ	NA	70.8%	120.4%	46.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	28.6	21.8	3.6	10.6	21.1	36.3	25.5	37.4	3.3
Op. Profit Mgn % ⓘ	17.3	15.1	14	17.9	24.5	34.7	27.5	30.8	NAN
Net Profit Mgn % ⓘ	9.3	7.2	1.4	5	11.3	24.9	19.9	23.4	11.4
Debt to Equity ⓘ	1.6	0.8	1	0	0.5	0	0.1	0	-
Working Cap Days ⓘ	0	162	181	96	99	182	226	251	0
Cash Conv. Cycle ⓘ	0	15	45	52	54	44	57	57	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	8.8	-
TTM Sales (₹ Cr.)	56.7	-
BVPS (₹) ⓘ	45.6	-
Reserves (₹ Cr.) ⓘ	26	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	7.4
Face Value (₹)	10
Industry PE ⓘ	43.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Swiss Parenterals - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Sales	40.66	47.03	48.35	48.29	56.69	223.32	291.29	361.58
Operating Expenses ⓘ +	33.65	40.12	41.59	39.64	42.82	145.82	212.24	250.23
Manufacturing Costs	9.18	10.94	11.85	9.84	13.55	15.11	30.57	24.48
Material Costs	19.51	23.41	22.31	20.54	19.24	92.56	116	162.01
Employee Cost	1.29	2.13	2.81	2.98	3.96	9.66	24.57	24.24
Other Costs ⓘ	3.67	3.63	4.61	6.28	6.07	28.49	41.10	39.50
Operating Profit ⓘ	7.01	6.91	6.76	8.65	13.87	77.50	79.05	111.35
Operating Profit Margin (%)	17.2%	14.7%	14.0%	17.9%	24.5%	34.7%	27.1%	30.8%
Other Income ⓘ +	0.21	0.34	0.33	0.68	0.71	11.87	27.54	10.18
Exceptional Items ⓘ	-0.16	-0.15	0	-0	-0	0	0	0
Interest ⓘ	0.70	1.11	2.07	1.69	1.19	0.98	0.24	0.22
Depreciation ⓘ	0.60	1.27	3.92	3.58	3.11	7.79	3.59	5.62
Profit Before Tax ⓘ	5.77	4.72	1.11	4.06	10.28	80.59	102.76	115.69
Tax ⓘ	2.04	1.58	0.39	1.43	3.81	21.50	32.82	30.55
Profit After Tax	3.72	3.15	0.72	2.63	6.46	59.09	69.94	85.14
PAT Margin (%)	9.2%	6.7%	1.5%	5.4%	11.4%	26.5%	24.0%	23.6%
Adjusted EPS (₹)	7.8	5.7	1.3	0.0	8.8	80.2	125.3	152.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	12.47	17.77	18.45	27.07	33.59	272.08	183.42	268.37
Share Capital ⓘ	1.06	1.24	1.24	1.64	7.37	7.37	5.58	5.58
Reserves ⓘ	11.42	16.53	17.21	25.43	26.21	264.71	177.84	262.79
Debt +	16.19	14.79	17.47	8.21	15.37	9.96	20.01	1.36
Long Term Debt	12.54	10.38	11.29	5.89	6.15	0	0	0
Short Term Debt	3.65	4.41	6.18	2.32	9.22	9.96	20.01	1.36
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	9.42	10.83	11.94	8.83	10.59	15.66	34.85	42.48
Others Liabilities ⓘ	9.22	4.07	11.13	6.01	8.03	41.79	87.41	92.37
Total Liabilities ⓘ	47.31	47.46	58.98	50.12	67.57	339.49	325.69	404.58
Fixed Assets
Net Fixed Assets ⓘ +	5.18	25.37	23.86	20.89	18.92	46.78	59.11	62.95
Gross Block	9.16	30.48	32.94	33.52	34.47	54.66	70.53	79.42
Accumulated Depreciation	3.98	5.11	9.08	12.63	15.54	7.88	11.42	16.47
CWIP ⓘ	14.85	0.26	0.18	0	4.21	1.81	0.21	11.71
Investments ⓘ	0	0	0	0	0	25.38	5	5
Inventories	11.03	7.74	9.95	7.49	8.76	23.21	36.17	28.95
Trade Receivables	6.43	6.35	14.98	9.91	19.09	49.27	81.13	89.03
Cash Equivalents	2.33	1.94	4.21	4.89	7.13	79.20	66.36	22.90
Others Assets ⓘ	7.49	5.80	5.80	6.94	9.46	113.84	77.71	184.04
Total Assets ⓘ	47.31	47.46	58.98	50.12	67.57	339.49	325.69	404.58

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	2.83	7.68	3.90	6.10	3.63	14.48	107.12	91.02
PBT ⓘ	5.77	4.72	1.11	4.06	10.28	80.59	102.76	115.69
Adjustment ⓘ	1.23	2.32	5.98	4.99	4.02	1.86	-19.02	0.01
Changes in Working Capital ⓘ	-2.12	1.74	-2.43	-1.22	-6.61	-43.87	54.65	-3.14
Tax Paid ⓘ	-2.06	-1.10	-0.76	-1.73	-4.06	-24.11	-31.27	-21.54
Cash Flow From Investing Activity ⓘ +	-12.43	-6.93	-2.24	-0.48	-7.37	-9.19	32.13	-68.51
Capex	-13.10	-6.87	-2.39	-0.74	-5.01	-2.57	-14.31	-22.41
Net Investments	0	0	0	0	0	-12.83	36.93	47.91
Others ⓘ	0.67	-0.06	0.15	0.27	-2.36	6.22	9.51	-94.01
Cash Flow From Financing Activity ⓘ +	10.74	-1.15	0.61	-4.95	5.97	10.07	-148.87	-19.04
Net Proceeds from Shares ⓘ	1.44	1.36	0	6	0	0	0	0
Net Proceeds from Borrowing ⓘ	8.74	-2.16	0.91	-5.40	0.27	0	0	0
Interest Paid ⓘ	-0.70	-1.11	-2.07	-1.69	-1.19	-0.22	-0.24	-0.15
Dividend Paid ⓘ	0	0	0	0	0	0	-55.82	0
Others ⓘ	1.26	0.75	1.77	-3.86	6.90	10.29	-92.81	-18.89
Net Cash Flow ⓘ	1.14	-0.39	2.27	0.68	2.23	15.37	-9.62	3.47

Finance Ratio

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	33.17	21.71	3.99	11.54	21.48	43.44	30.71	37.69
ROCE (%)	21.38	18.55	9.26	16.1	27.36	57.84	42.43	48.99
Asset Turnover Ratio	0.88	1.04	0.96	0.92	1.02	1.32	0.88	0.99
PAT to CFO Conversion(x)	0.76	2.44	5.42	2.32	0.56	0.25	1.53	1.07
Working Capital Days
Receivable Days	56.10	47.40	76.20	90.40	88.50	80.50	81.70	85.80
Inventory Days	96.30	69.60	63.20	63.30	49.60	37.90	37.20	32.80
Payable Days	176.30	157.90	186.30	184.50	184.20	30.90	79.50	87.10

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Swiss Parenterals Ltd FAQs

The current trading price of Swiss Parenterals on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Swiss Parenterals stood at ₹0.00 Cr

The latest P/E ratio of Swiss Parenterals as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Swiss Parenterals as of 31-Dec-1969 is 0.00.

The 52-week high of Swiss Parenterals is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Swiss Parenterals is ₹56.69 ( Cr.) .

About Swiss Parenterals Ltd

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Swiss Parenterals Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating